Here’s A Better Pharmaceutical Pick Over Merck Stock
- Tuesday, January 11, 2022, 7:14
- Market
- Add a comment
We think that Bristol Myers Squibb stock (NYSE: BMY) currently is a better pick compared to its industry peer, Merck stock (NYSE: MRK), given its better growth prospects and comparatively lower valuation, with its stock trading at 3.0x trailing revenues, compared to 3.6x for MRK stock…
About the Author
admin123 has written 23544 stories on this site.
